Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Obstetrics and Gynecology Clinics of North America|December 9, 2008
Cervical cancer screening in pregnancyKathleen McIntyre-Seltman, Jamie L Lesnock
Gynecologic Oncology|June 14, 2011
Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian cancerJamie L Lesnock, Coreen Farris, Thomas C Krivak, et al.
American Journal of Obstetrics and Gynecology|February 4, 2015
Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or olderMichelle R Rowland, Jamie L Lesnock, Coreen Farris, et al.
Gynecologic Oncology|April 27, 2023
Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancerTaylor J Orellana, Hayeon Kim, Sushil Beriwal, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2016
Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian CancerMichelle M Boisen, Jamie L Lesnock, Scott D Richard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 5, 2010
Intraperitoneal catheter leads to prolongation of the time to normalization of serum CA125 levelsScott D Richard, Paniti Sukumvanich, Jamie L Lesnock, et al.
International Journal of Radiation Oncology, Biology, Physics|September 14, 2014
National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancementsBeant S Gill, Jeff F Lin, Thomas C Krivak, et al.
American Journal of Clinical Oncology|April 23, 2025
The Role of Adjuvant Chemotherapy in Endometrial Cancer Following Preoperative Neoadjuvant Chemoradiation TherapyMargaret R Flanigan, Michelle Ertel, John A Vargo, et al.
Pageof 3